Nicholas Florko, STAT

Nicholas Florko

STAT

Washington, DC, United States

Contact Nicholas

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • STAT
Past:
  • CNBC
  • Scientific American

Recent articles by Nicholas:

To gin up opposition to the proposed menthol ban, tobacco companies are turning to gas station ads

At the Gateway mini mart in Gettysburg, you can buy menthol-flavored hemp cigarettes, an impressive 1 lb. bag of pipe tobacco, or a Dragon Ball Z-themed bong — or, you can submit a formal comment to regulators at the FDA. → Read More

FDA formally warns companies behind Family Guy vapes, other illegal products marketed at kids

The FDA is formally warning multiple companies they must stop selling vapes marketed to young people, including two that STAT highlighted in recent reporting on the industry. → Read More

White House’s Jha isn’t predicting a holiday Covid surge this year

“We are in a very different place and we will remain in a different place. ... A large chunk of Americans have gotten infected.” → Read More

The FDA has banned certain vapes and medicines. We still bought these 13 products in its backyard

The FDA is supposed to police the food and drug supply. But it's easy to find illegal products — including in the agency's own backyard. We know, we bought them. → Read More

California bans flavored tobacco products, including vapes

California voters passed a statewide ban on flavored vapes and other flavored tobacco products, including menthol cigarettes. → Read More

Missouri Senate race shows just how hard it is to campaign on abortion in the heartland

A relatively one-sided race in Missouri demonstrates that abortion alone may not be enough to sway voters in America’s heartland. → Read More

Tobacco companies shower Black Democrats with campaign cash

Tobacco companies generally don’t donate to many Democratic candidates for political office, but this election cycle, they're showering Black Democrats in particular with campaign cash. → Read More

FDA, DOJ sue 6 vape shops for ignoring warnings about selling illegal products

The Biden administration is suing six vape shops after the companies ignored FDA warnings that some of their products are illegal. → Read More

Youth vaping rates appear to be dropping, but regulators and advocates aren’t satisfied

A new survey from the CDC and the FDA suggests that youth vaping rates appear to be dropping, compared to pre-pandemic levels. → Read More

The U.S. is terrible at keeping businesses from worsening public health, experts say

STAT asked 10 experts to grade the United States' approach to preventing business from driving sickness and death. No one gave higher than a C+. → Read More

Juul exec slams FDA over its approach to regulating vaping

“The very integrity of the FDA review process is now called into question,” said Juul's Joe Murillo. → Read More

FDA appears to hold off on crackdown on synthetic nicotine products, despite calls from Congress

Congress gave the Food and Drug Administration a clear directive to crack down on vape companies skirting the agency’s rules. But there are growing signs the agency is not ready to do as instructed. → Read More

Court rules Juul can temporarily keep selling e-cigarettes while it prepares challenge to FDA ban

A federal court ruled Friday that Juul's vaping products can temporarily stay on the market while the company challenges the FDA's ban. → Read More

The Biden administration wants to get tough on states’ abortion pill restrictions. It won’t be easy

The Biden administration wants to get tough on states’ abortion pill restrictions. It won’t be easy. → Read More

FDA orders Juul e-cigarettes off the market in the U.S.

The FDA is pulling Juul products off the market because of concerning toxicology data and risk of “potentially harmful chemicals leaching from the company’s proprietary e-liquid pods.” → Read More

‘Too little too late’: Unpacking Biden’s moves to improve federal prisons’ response to Covid-19

Biden is trying to unsnarl federal prisons’ response to Covid, but experts say the latest moves also underscore just how much is still broken. → Read More

Pharma showers John Thune with campaign cash

All told, Sen. John Thune raked in more than $35,000 from pharmaceutical companies in February. → Read More

Flagship Pioneering hires lobbyists, a first among biotech venture firms

Flagship Pioneering, the venture capital firm behind Moderna, hired five lobbyists in Washington — a first among biotech-focused VCs. → Read More

Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs

Federal prisons used just a fraction of the antiviral drugs they were allocated to keep incarcerated people from getting seriously ill or dying of Covid-19, according to new internal records from the Bureau of Prisons. → Read More

The FDA's ban on menthol in cigarettes clears a major regulatory hurdle

The FDA’s highly anticipated — and contested — rule banning menthol in cigarettes could come out as soon as this week. → Read More